Significant Delays in Medicare Procedures Due to New Policy Changes
Keith Magnuson, an 83-year-old resident of Seattle, faces a significant delay in receiving a medical procedure due to changes in Medicare policy. Magnuson, who suffers from lumbar spinal stenosis, has been recommended for a minimally invasive lumbar decompression procedure, known as MILD, covered by Medicare. However, a recent pilot program initiated by Medicare has introduced additional hurdles.
Starting in 2026, Medicare launched a trial run to evaluate specific medical services across six states, including Washington. This program, active until 2031, seeks to minimize unnecessary medical expenses by utilizing advanced technologies such as artificial intelligence. As a result, Medicare patients must now obtain prior authorization through a third-party technology firm before receiving certain treatments.
This pilot marks a shift from Medicare's traditional practices, which historically lacked formalized prior authorization, unlike private insurers. While initially confined to 13 medical services, the program’s expansion could result in increased denials or delays in care. Healthcare providers and patients in Washington, where the pilot is underway, report challenges with the program's rollout.
Jennifer Brackeen of the Washington State Hospital Association noted extended wait times for approval, contrary to expectations of quicker processing through the use of AI. Virtix Health, tasked with handling authorizations in Washington, faced initial delays due to an unexpected influx of requests, causing further setbacks for patients. Virtix stated it is committed to adhering to response time standards and improving operations.
Incorporated measures require every request, at risk of denial, to be approved by a clinician rather than through AI alone, necessitating documentation that services are necessary. Shepherd, of the Washington State Medical Association, describes this process as administratively burdensome, while medical practices like pain management are particularly impacted. Magnuson encounters denial for an epidural steroid injection—integral to his treatment plan—under the WISeR pilot.
Efforts are ongoing to address the denial, illustrating the pilot's procedural complications. Dr. Brent Richardson acknowledges Medicare’s cost-saving intentions but highlights the impediments these present to timely patient care. For some patients, the delays can be financially and physically taxing. Magnuson himself has contemplated covering costs out-of-pocket, a challenging prospect given regulations against direct patient billing for Medicare-covered services.
As some individuals forego care or pay independently, there are growing concerns about aligning WISeR’s cost-saving goals with patient welfare. The ongoing feedback and developments within CMS and its partners, including Virtix, remain crucial to refining the program's efficiency and patient experience.